Quemliclustat
Small moleculeexperimental
Clinical trial activity
11 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
8
Phase 3
1
Phase 4
0
Earliest trial started Oct 8, 2018 (NCT03677973)
Timeline
Indications
Mechanism of action
- 5'-nucleotidaseINHIBITOR
NT5E inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
C[C@H](Nc1cc(Cl)nc2c1cnn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O)c1ccccc1F- Mol. weight
- 580.83 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4471306 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06608927 | Phase 3 | Nov 30, 2024 | Arcus Biosciences, Inc., Otsuka |
| NCT06048133 | Phase 2 | Dec 31, 2023 | Arcus Biosciences, Inc., Big Ten Cancer Research Consortium, Gilead Sciences, University of Wisconsin |
| NCT06048484 | Phase 2 | Oct 31, 2023 | Arcus Biosciences, Inc., Columbia University |
| NCT05915442 | Phase 2 | Jul 1, 2023 | Arcus Biosciences, Inc., Columbia University |
| NCT05688215 | Phase 1/Phase 2 (Phase 2) | Mar 7, 2023 | Arcus Biosciences, Inc., University of California, Los Angeles |
| NCT05676931 | Phase 2 | Feb 1, 2023 | Arcus Biosciences, Inc., Gilead Sciences |
| NCT04660812 | Phase 1/Phase 2 (Phase 2) | May 10, 2021 | Arcus Biosciences, Inc. |
| NCT04575311 | Phase 1 | Oct 20, 2020 | Arcus Biosciences, Inc. |
| NCT04381832 | Phase 1/Phase 2 (Phase 2) | May 31, 2020 | Arcus Biosciences, Inc. |
| NCT04104672 | Phase 1 | Oct 21, 2019 | Arcus Biosciences, Inc. |
| NCT03677973 | Phase 1 | Oct 8, 2018 | Arcus Biosciences, Inc. |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Arcus Biosciences, Inc. | For profit | 11 | 7 | 3 | 2018 |
| Columbia University | Academic/Hospital | 2 | 2 | 1 | 2023 |
| Gilead Sciences | For profit | 2 | 0 | 1 | 2023 |
| Big Ten Cancer Research Consortium | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Otsuka | For profit | 1 | 0 | 1 | 2024 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2023 |
| University of Wisconsin | Academic/Hospital | 1 | 0 | 1 | 2023 |
7 organizations
Page 1 / 1